Dr Katherine Ruzhansky previews presentations on biomarkers, new therapies, and translational science at AANEM 2025.
Insights from AANEM 2025, including anticipated presentations, key takeaways, and how emerging research in myasthenia gravis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback